1,661
Views
6
CrossRef citations to date
0
Altmetric
Cardiovascular

Bisoprolol/amlodipine combination therapy improves blood pressure control in patients with essential hypertension following monotherapy failure

, &
Pages 1735-1743 | Received 24 May 2016, Accepted 20 Jun 2016, Published online: 04 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ulrike Hostalek-Gottwald & Zbigniew Gaciong. (2022) A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension. Current Medical Research and Opinion 38:7, pages 1047-1053.
Read now

Articles from other publishers (4)

Junxiong Lin, Qinghui Guo, Zhuoqiang Lu, Dajun Chai, Feng Peng & Jinxiu Lin. (2023) Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study. The Journal of Clinical Hypertension 25:5, pages 440-452.
Crossref
O. A. Polyakova, O. D. Ostroumova, E. V. Mironova, N. M. Doldo, A. I. Listratov & A. V. Filippov. (2021) Prospects for the use of a fixed combination of bisoprolol and amlodipine in the treatment of patients with post-covid syndrome. Meditsinskiy sovet = Medical Council:14, pages 23-34.
Crossref
Sohila M Elonsy, Fawzy A El Yazbi, Rasha A Shaalan, Hytham M Ahmed & Tarek S Belal. (2021) Application of MEKC and UPLC with Fluorescence Detection for Simultaneous Determination of Amlodipine Besylate and Bisoprolol Fumarate. Journal of AOAC INTERNATIONAL 104:2, pages 339-347.
Crossref
Chaoying Hu, Xiao Hu, Chunhua Wang, Zirun Zhao, Dan Gao, Xiaoping Chen, Dongli Zhou, Yue Huang, Lin Li & Lan Zhang. (2018) Bioequivalence and Pharmacokinetics of Bisoprolol–Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects. Clinical Drug Investigation 38:12, pages 1145-1154.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.